Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience

被引：0
|
作者：
Kamal Chamoun
Hagop Kantarjian
Rami Atallah
Graciela Nogueras Gonzalez
Ghayas C. Issa
Mary Beth Rios
Guillermo Garcia-Manero
Gautam Borthakur
Farhad Ravandi
Nitin Jain
Naval Daver
Marina Konopleva
Courtney D. DiNardo
Tapan Kadia
Naveen Pemmaraju
Elias Jabbour
Jorge Cortes
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Leukemia
[2] The University of Texas MD Anderson Cancer Center,Department of Biostatistics
来源：
Journal of Hematology & Oncology | / 12卷
关键词：
CML; TKI discontinuation; MR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] The Impact of Pretransplant Use of Tyrosine Kinase Inhibitors on Allogeneic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia - A Single-institution Retrospective Study -
    Fujita, Shinya
    Kasahara, Hidenori
    Kato, Jun
    Koda, Yuya
    Shiroshita, Kohei
    Yamaguchi, Kentaro
    Okayama, Mikio
    Abe, Ryohei
    Kikuchi, Taku
    Shimizu, Takayuki
    Mori, Takehiko
    Kataoka, Keisuke
    Okamoto, Shinichiro
    INTERNAL MEDICINE, 2023, 63 (11) : 1549 - 1562
  • [42] Cladribine in the Treatment of Acute Myeloid Leukemia: A Single-Institution Experience
    Martin, Mike G.
    Welch, John S.
    Augustin, Kristan
    Hladnik, Lindsay
    DiPersio, John E.
    Abboud, Camille N.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (04): : 298 - 301
  • [43] Withdrawal syndrome after tyrosine kinase inhibitors discontinuation in patients with chronic myeloid leukemia
    Chelysheva, Ekaterina Yu
    Petrova, Anna N.
    Shukhov, Oleg A.
    Bykova, Anastasiia, V
    Nemchenko, Irina S.
    Gurianova, Margarita A.
    Tsyba, Nikolay N.
    Turkina, Anna G.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (07) : 836 - 843
  • [44] Tyrosine Kinase Inhibitor Therapy Discontinuation for Patients with Chronic Myeloid Leukaemia in Clinical Practice
    Richard E. Clark
    Current Hematologic Malignancy Reports, 2019, 14 : 507 - 514
  • [45] Tyrosine Kinase Inhibitor Therapy Discontinuation for Patients with Chronic Myeloid Leukaemia in Clinical Practice
    Clark, Richard E.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (06) : 507 - 514
  • [46] Does the Frequency of Molecular Monitoring After Tyrosine Kinase Inhibitor Discontinuation Affect Outcomes of Patients With Chronic Myeloid Leukemia?
    Kong, Jee Hyun
    Winton, Elliott F.
    Heffner, Leonard T.
    Chen, Zhengjia
    Langston, Amelia A.
    Hill, Brittany
    Arellano, Martha
    El-Rassi, Fuad
    Kim, Audrey
    Jillella, Anand
    Kota, Vamsi K.
    Bodo, Imre
    Khoury, Hanna Jean
    CANCER, 2017, 123 (13) : 2482 - 2488
  • [47] Musculoskeletal Pain in Patients With Chronic Myeloid Leukemia After Discontinuation of Imatinib: A Tyrosine Kinase Inhibitor Withdrawal Syndrome? Reply
    Rousselot, Philippe
    Charbonnier, Aude
    Cony-Makhoul, Pascale
    Agape, Philippe
    Nicolini, Franck E.
    Varet, Bruno
    Gardembas, Martine
    Etienne, Gabriel
    Rea, Delphine
    Roy, Lydia
    Escoffre-Barbe, Martine
    Guerci-Bresler, Agnes
    Tulliez, Michel
    Prost, Stephane
    Spentchian, Marc
    Cayuela, Jean Michel
    Reiffers, Josy
    Chomel, Jean Claude
    Turhan, Ali
    Guilhot, Joelle
    Guilhot, Francois
    Mahon, Francois-Xavier
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) : 2823 - +
  • [48] Management of chronic myeloid leukemia during pregnancy among patients treated with a tyrosine kinase inhibitor: a single-Center experience
    Assi, Rita
    Kantarjian, Hagop
    Keating, Michael
    Pemmaraju, Naveen
    Verstovsek, Srdan
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Borthakur, Gautam
    Dahl, Jenny
    Jabbour, Elias
    Cortes, Jorge E.
    LEUKEMIA & LYMPHOMA, 2021, 62 (04) : 909 - 917
  • [49] Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: when and for whom?
    Atallah, Ehab
    Schiffer, Charles A.
    HAEMATOLOGICA, 2020, 105 (12) : 2738 - 2745
  • [50] Impact of Health Care Funding on Compliance and Survival in Patients with Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Single Institution Experience
    Pasam, Avinash
    Comeau, Jill
    Shi, Runhua
    Devarakonda, Srinivas S.
    BLOOD, 2015, 126 (23)
12345